← Human Trials & Peer-Reviewed Studies
Circulating miRNAs and childhood asthma ICS response: a stratified analysis in the intervention arm of an RCT with vitamin D effect modification.
Plain-language guide to PMID 40467329 (2025): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 462 subjects.
Key Facts
- PMID
- 40467329
- Journal
- Thorax
- Year
- 2025
- Study type
- Randomized Controlled Trial
- Authors
- Jiang M et al. (13 authors)
- DOI
- 10.1136/thorax-2024-222618
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.
The researchers hypothesised that vitamin D influences long-term ICS response through miRNA regulation.
Why It Was Studied
MiRNAs play a crucial role in the anti-inflammatory effects of inhaled corticosteroids (ICS) in asthma.
Who Took Part
According to the abstract, 462 subjects were involved.
By PubMed's age tags, the people studied were children, both men and women.
Baseline serum miRNAs were sequenced from 462 subjects in the Childhood Asthma Management Program (CAMP), with 187 randomised to ICS treatment included in this study.
Microarray analysis of lymphoblastoid B cells (lymphoblastoid cell lines (LCLs)) from 22 CAMP subjects treated with dexamethasone (DEX), vitamin D or sham identified differentially expressed genes (DEGs).
How the Study Was Run
The design is described as randomized.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
An miRNA target gene network was constructed, clustered and annotated by enrichment analysis.
Top miRNAs were evaluated for ICS response prediction.
What Was Measured
Topics PubMed links to this paper include Asthma, Vitamin D, Circulating MicroRNA, Administration, Inhalation, MicroRNAs, Forced Expiratory Volume and Adrenal Cortex Hormones.
Author keywords: Asthma Mechanisms, Child and Paediatric asthma.
What This Means in Plain Language
The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 462 subjects.
With several hundred people or more, it is a fairly large study for this kind of research.
The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2025 (Thorax), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.